Cafepharma Today

November 8 2024 - Pfizer makes $1B commitment in China to boost innovation, targets Chinese market
Pfizer makes $1B commitment in China to boost innovation, targets Chinese market
What RFK Jr.’s influence could mean for pharma
Eisai dials back forecasts for Alzheimer's drug Leqembi
J&J joins Medtronic & Boston Sci in PFA race with FDA approval of Varipulse
*please scroll down for all the latest news*

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

*please scroll down for all the latest news*

Current News

submit a press release

Suspended Judgment On Vertex
Forbes
Tuesday, October 21, 2008 - 9:57am
tags:
Pozen stock slides as 2 analysts cut ratings due to FDA questions on 2 drug candidates
Yahoo/AP
Tuesday, October 21, 2008 - 9:55am
tags:
Depomed starts second test of hot flash drug
Bizjournals.com
Tuesday, October 21, 2008 - 9:53am
tags:
Chantix and Lipitor Sales Fall, But Pfizer’s Earnings Rise
WSJ Online
Tuesday, October 21, 2008 - 9:42am
tags:
Lilly to take $1.4 billion charge related to Zyprexa probe
Marketwatch
Tuesday, October 21, 2008 - 9:41am
tags:
Schering beats forecast, as Vytorin falls
Yahoo/Reuters
Tuesday, October 21, 2008 - 9:38am
tags:
Avigen says Phase 2 MS drug trial fails to meet goal
Marketwatch
Tuesday, October 21, 2008 - 9:37am
tags:
Novartis to Buy Nektar's Pulmonary Business
The Street.com
Tuesday, October 21, 2008 - 9:33am
tags:
Abbott Labs says regulators request more info on controlled-release painkiller Vicodin
Yahoo/AP
Tuesday, October 21, 2008 - 9:32am
tags:
Novartis Moves to the Next Stage
Businessweek
Tuesday, October 21, 2008 - 9:31am
tags:
Amgen up 15 pct year-to-date; hope for blockbuster osteoporosis drug defends against declines
Yahoo/AP
Tuesday, October 21, 2008 - 9:30am
tags:
Novartis & Biotechs: ‘I Don’t Think We’ve Seen the Trough’
WSJ Online
Tuesday, October 21, 2008 - 9:29am
tags:
Foolish Forecast: Will Pfizer Flounder Through Another Quarter?
Motley Fool
Tuesday, October 21, 2008 - 9:28am
tags:
Takeda Rises as Buyback Plan Outweighs Drug Delays
Bloomberg
Tuesday, October 21, 2008 - 9:27am
tags:
Novartis CEO Seeks Biotechs Needing Funds, Investors
Bloomberg
Tuesday, October 21, 2008 - 9:26am
tags:
Actavis plays down sale rumours
FT.com
Monday, October 20, 2008 - 11:33am
tags:
Biogen works to stave off proxy fights
Fierce Pharma
Monday, October 20, 2008 - 11:32am
tags:
Drug stocks move forward with broader market
Marketwatch
Monday, October 20, 2008 - 11:30am
tags:
[video]TheStreet.com BioTalk: Big-Cap Breakdown
The Street.com
Monday, October 20, 2008 - 11:22am
tags:
Don't Get Burned by the Next Cell Genesys
The Street.com
Monday, October 20, 2008 - 10:45am
tags:

Pages

Latest CP Wire Articles

Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies
Sapio Sciences launches new drug discovery platform
Bristol Myers Squibb Strengthens and Diversifies Oncology Portfolio With Acquisition of Mirati Therapeutics
Why Medical and Pharma Sales Reps Should Start Their Own Senior Care Business
Bend Bioscience Adds Capacity and Technology Offerings with the Addition of New Process and Manufacturing Science Facility

Latest Pharmagather Articles

How the Perfect Storm Will Impact Patient Support Programming in 2025 and Beyond
Drug Channels
The Choice Made
In the Pipeline
Just How Lipophilic Is That Huge Thing?
In the Pipeline
Down in the Mantle
In the Pipeline
Transparency Shocker: Biosimilars Are Getting Cheaper—But Hospitals and Insurers Can Make Them Expensive
Drug Channels
How Field Reimbursement Services Help Overcome Coverage Barriers and Improve Patient Outcomes
Drug Channels
Anti-Bredt Olefins: Never Say Never!
In the Pipeline
Eli Lilly's Earnings
In the Pipeline
The Choice
In the Pipeline

Latest Jobs

Pharmaceutical Sales Customer Engagement, CNS - Morgantown, WV
Morgantown, West Virginia, 26501
Otsuka
Territory Manager, Medical Dermatology - Omaha, NE
Julian, Nebraska, 68379
Sun Pharmaceutical Industries, Inc.
Pharmaceutical Sales Customer Engagement- Tampa
Tampa, Florida, 33646
Otsuka
Pharmaceutical Sales Customer Engagement- Washington, DC
Washington, District of Columbia, 20022
Otsuka
Pharmaceutical Sales Customer Engagement - Eugene, OR
Eugene, Oregon, 97403
Otsuka
Pharmaceutical Sales Customer Engagement - Atlanta East, GA
Atlanta, Georgia, 30383
Otsuka
Pharmaceutical Sales Customer Engagement- Columbus, OH
Columbus, Ohio, 43224
Otsuka
Pharmaceutical Sales Customer Engagement, CNS - Baltimore S, MD
Baltimore, Maryland, 21276
Otsuka
Pharmaceutical Sales Customer Engagement, CNS - Allentown, PA
Allentown, Pennsylvania, 18103
Otsuka
Territory Manager, Medical Dermatology - Sacramento, CA
Clarksburg, California, 95612
Sun Pharmaceutical Industries, Inc.
more jobs

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.

Do Not Allow Advertisers to Use My Personal information